Shares in BioDelivery Sciences International (NSDQ:BDSI) fell today after the pharmaceutical company beat sales estimates but missed earnings expectations on Wall Street with its second quarter results.
The Raleigh, N.C.-based company posted a net loss of -$14.9 million on sales of $8.7 million for the 3 months ended June 30, paring losses by 9.7% on sales growth of 75% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post BioDelivery Sciences beats Q2 rev estimates, misses on EPS appeared first on MassDevice.
from MassDevice http://ift.tt/2hNh5zf
Cap comentari:
Publica un comentari a l'entrada